Puma Biotechnology, Inc. (PBYI)
6.385
-0.04
(-0.55%)
USD |
NASDAQ |
Jan 15, 16:00
6.385
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology SG&A Expense (TTM): 69.09M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Nephros, Inc. | 8.556M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Vanda Pharmaceuticals, Inc. | 214.26M |
| CorMedix, Inc. | 75.56M |
| Relmada Therapeutics, Inc. | 28.04M |